Skip to content
News & Events Ribociclib plus Letrozole

Ribociclib plus Letrozole

Ribociclib plus letrozole versus letrozole alone in patients with de novo HR+, HER2- advanced breast cancer in the randomized MONALEESA-2 trial.

O’Shaughnessy J, Petrakova K, Sonke GS, Conte P, Arteaga CL, Cameron DA, Hart LL, Villanueva C, Jakobsen E, Beck JT, Lindquist D, Souami F, Mondal S, Germa C, Hortobagyi GN.

Breast Cancer Res Treat. 2017 Nov 21. doi: 10.1007/s10549-017-4518-8. [Epub ahead of print]

PMID: 29164421